Serum Institute expects WHO emergency approval for AstraZeneca shot soon

Credit: IndiaTimes- Published on January 14, 2021
The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief executive said.

Video credit: ANI
Published on January 16, 2021 -  02:39
Nepal: People cheers after approval of Covishield vaccine manufactured in India
After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

You are here

๐Ÿ’ก newsR Knowledge: Other News Mentions


British-Swedish pharmaceutical company
After Canada approved AstraZenecaโ€™s Covid-19 vaccine, 500,000 doses of the same vaccine manufactured in India will arrive in Canada on Wednesday. Canadian..
Credit: IndiaTimes - Published 3 hours ago

Related videos from verified sources

Canada approves AstraZeneca's COVID-19 shot 01:30
Credit: Reuters Studio - Published 1 day ago 

Nepal begins nationwide inoculation drive against coronavirus pandemic 01:54
Credit: ANI - Published on January 27, 2021 

Five dead after fire breaks out at Serum Institute in Pune, western India 00:33
Credit: Newsflare STUDIO - Published on January 21, 2021 

Related news from verified sources

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for...
on January 14, 2021 • IndiaTimes

India moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending...
on January 1, 2021 • IndiaTimes

With the Drug Controller General of India (DCGI) approving Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use,...
on January 4, 2021 • IndiaTimes

You might like